Scientific Publications Database

Article Title: ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)
Authors: Morgensztern, D.; Ong, T. J.; Dols, M. Cobo; Aix, S. Ponce; Postmus, P. E.; Lewanski, C.; Bennouna, J.; Fischer, J. R.; Vidal, O. J.; Stewart, D. J.; Fasola, G.; Ardizoni, A.; Weaver, J.; Wolfsteiner, M.; Talbot, D.; Govindan, R.
Journal: ANNALS OF ONCOLOGY Volume 28
Date of Publication:2017
Abstract:
.